Discovery on Target 2018 | Engineering NK Cells for Enhanced Potency and Persistence

Update: 2018-08-16

Description

Dr. James Trager shares a preview of his talk at the NK cell-based cancer immunotherapy meeting in Boston, discusses his next step in research and the vision of Nkarta in NK cell therapy development and what he’s looking forward to at this meeting such as the topics of inhibition of MIC protein shedding and NK cell metabolism.

For more information, please visit http://www.DiscoveryOnTarget.com/NK-Cell-Based-Cancer-Immunotherapy/

Comments

In Channel

Molecular Med Tri-Con 2020 | Artificial Intelligence in Precision Medicine

2020-01-1523:48

Molecular Med TriCon 2019 | Gene Therapy for Rare Disorders

2019-12-1714:00

Immunogenicity Summit 2019 | From Cell & Gene Therapy to Biostatistics

2019-08-0607:50

Next Generation Dx 2019 | Launch a Paradigm Shift through an Innovative Diagnostic Test

2019-06-0511:36

the Liquid Biopsy Summit 2019 | Reimagining Liquid Biopsy Applications with Epigenomics

2019-03-2611:43

Molecular DX Europe 2019 | Using Point-of-Care Diagnostics to Advance a One Health Approach

2019-03-0508:35

Molecular Med Tri-Con 2019 | Putting the AI in Wait

2019-03-0107:46

Molecular Med Tri-Con 2019 | Real Precision Medicine is Starting with the Patient

2019-02-1810:00

Molecular Med Tri-Con 2019 | Target the Tumor Mutational Burden and Pursue Harmonization

2019-02-1511:10

PEGS Boston 2019 | Jennifer Chadwick’s Story of Building a Creative and Authentic Career in Science

2019-02-0812:24

Bio-IT World | Advancing Life Sciences Research: Accelerating innovation in the age of cloud

2019-01-1809:41

Molecular Med Tri-Con 2019 | Personalized Estimation of Motality Risk

2018-11-0109:54

Information Technology in Support of Genetics in the Clinic

2018-08-2107:10

Leveraging Health Information Exchange to Achieve Population Health Surveillance

2018-08-2109:03

Population Segmentation and Care Management in R&D of New Therapeutics

2018-08-2113:59

Discovery on Target 2018 | Reprogramming Tumor Microenvironment to Enhance Immunotherapy

2018-08-1610:22

Discovery on Target 2018 | Novel Strategies to Produce Better NK Cells for Cancer Treatment

2018-08-1609:42

Discovery on Target 2018 | Engineering NK Cells for Enhanced Potency and Persistence

2018-08-1608:03

PEGS Europe 2018 | Transient Protein Gene Expression and Biotherapeutics

2018-07-2308:24

Bispecific Antibody Pipeline Congress 2018 | Checkpoint-binding Bispecific Antibodies

2018-07-1704:15

00:00

Discovery on Target 2018 | Engineering NK Cells for Enhanced Potency and Persistence

Cambridge Healthtech Podcasts

#box-pro-ellipsis-176410796595020{-webkit-line-clamp:2;}Discovery on Target 2018 | Engineering NK Cells for Enhanced Potency and Persistence

Discovery on Target 2018 | Engineering NK Cells for Enhanced Potency and Persistence

Cambridge Healthtech Podcasts

Discovery on Target 2018 | Engineering NK Cells for Enhanced Potency and Persistence